Effects of the Selective Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function and Central Hemodynamics in Patients With Type 2 Diabetes Mellitus. Issue 12 (19th September 2017) - Striepe, Kristina; Jumar, Agnes; Ott, Christian; Karg, Marina V.; Schneider, Markus P.; Kannenkeril, Dennis; Schmieder, Roland E.